ESOPHAGOGASTRIC JUCTION CANCER
Clinical trials for ESOPHAGOGASTRIC JUCTION CANCER explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGOGASTRIC JUCTION CANCER trials appear
Sign up with your email to follow new studies for ESOPHAGOGASTRIC JUCTION CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for esophageal cancer: study tests best Pre-Surgery combo
Disease control Recruiting nowThis study aims to find the best treatment before surgery for people with esophageal or stomach cancer. It compares chemotherapy, chemoradiation, targeted therapy, and immunotherapy. The goal is to improve survival and reduce side effects. About 2000 adults with stage I to IVa ca…
Matched conditions: ESOPHAGOGASTRIC JUCTION CANCER
Phase: PHASE3 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 26, 2026 04:52 UTC
-
New hope for tough cancers: experimental drug JR8603 enters human trials
Disease control Recruiting nowThis early-stage trial tests an investigational drug called JR8603 in about 94 adults with advanced solid tumors (including stomach, junction, and colorectal cancers) whose prior treatments have stopped working. The main goals are to check safety, find the best dose, and see if t…
Matched conditions: ESOPHAGOGASTRIC JUCTION CANCER
Phase: PHASE1 • Sponsor: JiaRay Group • Aim: Disease control
Last updated May 26, 2026 04:51 UTC